<SEC-DOCUMENT>0000899243-16-021505.txt : 20160602
<SEC-HEADER>0000899243-16-021505.hdr.sgml : 20160602
<ACCEPTANCE-DATETIME>20160602170037
ACCESSION NUMBER:		0000899243-16-021505
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160601
FILED AS OF DATE:		20160602
DATE AS OF CHANGE:		20160602

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REGENXBIO Inc.
		CENTRAL INDEX KEY:			0001590877
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		9712 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 100
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-552-8181

	MAIL ADDRESS:	
		STREET 1:		9712 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 100
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	REGENXBIO, Inc.
		DATE OF NAME CHANGE:	20150116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ReGenX Biosciences, LLC
		DATE OF NAME CHANGE:	20131101

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Samuels Camille D
		CENTRAL INDEX KEY:			0001354034

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37553
		FILM NUMBER:		161693197

	MAIL ADDRESS:	
		STREET 1:		2463 JACKSON ST.
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94115
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2016-06-01</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001590877</issuerCik>
        <issuerName>REGENXBIO Inc.</issuerName>
        <issuerTradingSymbol>RGNX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001354034</rptOwnerCik>
            <rptOwnerName>Samuels Camille D</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O REGENXBIO INC.</rptOwnerStreet1>
            <rptOwnerStreet2>9712 MEDICAL CENTER DRIVE, SUITE 100</rptOwnerStreet2>
            <rptOwnerCity>ROCKVILLE</rptOwnerCity>
            <rptOwnerState>MD</rptOwnerState>
            <rptOwnerZipCode>20850</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>12.74</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2016-06-01</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>12500</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2026-06-01</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>12500</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>12500</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option will vest in twelve (12) equal monthly installments following June 1, 2016.</footnote>
        <footnote id="F2">Under an agreement between the reporting person and VR Management, LLC (the &quot;Management Company&quot;), the reporting person is deemed to hold the reported securities for the sole benefit of the Management Company. The Management Company may be deemed the indirect beneficial owner of the reported securities, and the reporting person may be deemed the indirect beneficial owner of the reported securities through her interest in the Management Company. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Camille Samuels</signatureName>
        <signatureDate>2016-06-01</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
